bluebird bio Inc (NAS:BLUE)
$ 0.6063 0.0323 (5.63%) Market Cap: 116.86 Mil Enterprise Value: 240.32 Mil PE Ratio: 0 PB Ratio: 0.29 GF Score: 25/100

bluebird bio Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 03, 2021 / 07:40PM GMT
Release Date Price: $18.99 (-4.74%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

So good afternoon, everybody, and thank you once again for joining us for the 41st Annual Cowen Health Care Conference. I'm Yaron Werber from the biotech team, and it's a great pleasure to moderate the fireside chat with bluebird bio. We have Nick Leschly, Chief bluebird; Phil Gregory, Chief Scientific Officer; and Chip Baird, Chief Financial Officer. Gentlemen, thanks so much. I really appreciate you joining us, and it's really timely to get an update.

So Nick, do you want to maybe do the forward-looking statements and then we'll go into Q&A.

Nick Leschly
bluebird bio, Inc. - President, CEO & Director

Yes. You bet. First, thanks for having us. I think it is very timely. So I think it will be a good discussion.

So good afternoon, everyone. Before I begin, I would like to remind you that part of our conversation today will be making forward-looking statements about an ongoing investigation in the 2 safety events on the HGB-206

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot